Purpose of review: This clinical update is intended to focus in relationship between HIV infection and use of antiretroviral therapy (ART) and statin.
Recent findings: Though ART significantly changed the course of HIV infection, it is related to numerous side effects principally to the lipid profile. In this way, statins became one of the most used lipid-lowering therapies in this population. In our clinical update, we evaluated studies that demonstrate the relationship and molecular mechanisms that HIV infection and ART use trigger dyslipidemia and also the use of statin to reduce this condition. We have demonstrated that use of statin can be used in dyslipidemic HIV-infected people as long as there is no drug interaction with ART. Recently, studies using rosuvastatin have shown greater effects when compared to the other statins.
Keywords: Antiretroviral therapy; Cardiovascular disease; HIV; HMG-CoA reductase inhibitor.